Patent · US Active

Growth factor which acts through ErbB-4 RTK

US7981997B2 · kind B2 · utility

2Cited by
7References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2009
Grant dateJul 19, 2011
Priority date—
Expiry dateAug 12, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides for isolated polypeptides capable of binding ErbB-4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.